The Role of Brentuximab Vedotin (BV) as Second-Line Treatment of Refractory Classical Hodgkin Lymphoma (cHL) in the Era of Pandemic COVID-19 by Rajabto W, Chandika V, Harahap AS, Ham MF

Subjects: Get full text

Assessment of Effectiveness and Adverse Effect of New Combination Chemotherapy (irinotecan, cisplatin, and dexamethasone) in Relapse and Refractory Hodgkin Lymphoma by Mahdi Tabarraee, Atefeh Rezaee, Sara Abolghasemi, Mojtaba Ghadiany, Maria Tavakoli Ardakani, Mahshid Mahdizadeh, Neda Hamidi, Katayoon Ghasemi

Subjects: “…Relapse; Refractory; Hodgkin lymphoma; Irinotecan; Cisplatin; Salvage chemotherapy…”
Get full text

High frequency of primary refractory disease and low progression-free survival rate of Hodgkin's lymphoma: a decade of experience in a Latin American center by José Carlos Jaime-Pérez, Carmen Magdalena Gamboa-Alonso, José Ramón Padilla-Medina, Raúl Alberto Jiménez-Castillo, Leticia Alejandra Olguín-Ramírez, César Homero Gutiérrez-Aguirre, Olga Graciela Cantú-Rodríguez, David Gómez-Almaguer

Subjects: Get full text

Stem-Cell Transplantation in Adult Patients with Relapsed/Refractory Hodgkin Lymphoma by Sonja Genadieva Stavrik, Anna Sureda

Subjects: “…relapsed/refractory Hodgkin lymphoma…”
Get full text

Advances in the treatment of Hodgkin lymphoma: Current and future approaches by Fauzia Ullah, Danai Dima, Danai Dima, Najiullah Omar, Olisaemeka Ogbue, Sairah Ahmed

Subjects: “…relapsed and refractory Hodgkin's lymphoma…”
Get full text